Yanli Jin

2.2k total citations
45 papers, 1.5k citations indexed

About

Yanli Jin is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Yanli Jin has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Hematology and 9 papers in Genetics. Recurrent topics in Yanli Jin's work include Chronic Myeloid Leukemia Treatments (21 papers), Cancer-related gene regulation (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Yanli Jin is often cited by papers focused on Chronic Myeloid Leukemia Treatments (21 papers), Cancer-related gene regulation (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Yanli Jin collaborates with scholars based in China, United States and Italy. Yanli Jin's co-authors include Jingxuan Pan, Zhongzheng Lu, Xin Du, Jingfeng Zhou, Bei Jin, Ke Ding, Yongbin Wu, Yingrong Lai, Jing Zhou and Xiaoyong Sun and has published in prestigious journals such as Journal of Clinical Investigation, Cell Metabolism and Cancer Research.

In The Last Decade

Yanli Jin

43 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Jin China 23 1.1k 299 289 179 151 45 1.5k
Raquel Ciuvalschi Maia Brazil 23 765 0.7× 339 1.1× 555 1.9× 185 1.0× 40 0.3× 96 1.5k
Zhijian Xiao China 23 775 0.7× 560 1.9× 192 0.7× 189 1.1× 31 0.2× 117 1.5k
Fujun Li China 20 607 0.6× 155 0.5× 345 1.2× 202 1.1× 35 0.2× 62 1.3k
Randall Evans United States 13 609 0.6× 91 0.3× 220 0.8× 132 0.7× 129 0.9× 24 991
Jing Wen United States 17 522 0.5× 367 1.2× 454 1.6× 142 0.8× 33 0.2× 39 1.4k
Muxiang Zhou United States 26 1.6k 1.5× 291 1.0× 893 3.1× 525 2.9× 63 0.4× 51 2.3k
Noriko Yoneda‐Kato Japan 23 1.3k 1.2× 238 0.8× 396 1.4× 192 1.1× 19 0.1× 35 1.7k
Lubing Gu United States 24 1.2k 1.1× 147 0.5× 701 2.4× 313 1.7× 60 0.4× 39 1.6k
Fankai Meng China 19 612 0.6× 111 0.4× 327 1.1× 283 1.6× 49 0.3× 70 1.1k
Antonella Rigo Italy 21 550 0.5× 135 0.5× 432 1.5× 195 1.1× 29 0.2× 60 1.4k

Countries citing papers authored by Yanli Jin

Since Specialization
Citations

This map shows the geographic impact of Yanli Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Jin more than expected).

Fields of papers citing papers by Yanli Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Jin. The network helps show where Yanli Jin may publish in the future.

Co-authorship network of co-authors of Yanli Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Jin. A scholar is included among the top collaborators of Yanli Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Jin. Yanli Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Fen, et al.. (2025). SMYD3 Activates Fatty Acid β-Oxidation to Promote Self-Renewal of Leukemia Stem Cells. Cancer Research. 85(11). 2027–2045.
2.
Zhou, Min, Yi Huang, Ping Xu, et al.. (2024). PRMT1 Promotes the Self‐renewal of Leukemia Stem Cells by Regulating Protein Synthesis. Advanced Science. 12(5). e2308586–e2308586. 5 indexed citations
3.
Zhou, Fangyu, Fangyuan Wang, Yuanyuan Jiang, et al.. (2023). C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathy. International Immunopharmacology. 125(Pt A). 111065–111065. 6 indexed citations
4.
Jin, Yanli, Chunyan Yu, Chunmei Jiang, et al.. (2020). PtiCYP85A3, a BR C-6 Oxidase Gene, Plays a Critical Role in Brassinosteroid-Mediated Tension Wood Formation in Poplar. Frontiers in Plant Science. 11. 468–468. 14 indexed citations
5.
Wang, Haihai, Xiaoqing Wang, Chunyan Yu, et al.. (2020). MYB transcription factor PdMYB118 directly interacts with bHLH transcription factor PdTT8 to regulate wound-induced anthocyanin biosynthesis in poplar. BMC Plant Biology. 20(1). 173–173. 47 indexed citations
6.
Liu, Chang, Danian Nie, Juan Li, et al.. (2018). Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells. Cancer Research. 78(6). 1522–1536. 26 indexed citations
7.
Zhou, Jingfeng, Danian Nie, Juan Li, et al.. (2017). PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia. Clinical Cancer Research. 24(1). 145–157. 27 indexed citations
8.
Jin, Yanli, Ping Zhang, Yun Wang, et al.. (2017). Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma. Clinical Cancer Research. 24(15). 3741–3754. 48 indexed citations
9.
Wang, Yun, Maoxing Liu, Yanli Jin, Sheng Jiang, & Jingxuan Pan. (2017). In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor. Cancer Letters. 400. 47–60. 33 indexed citations
10.
Jin, Yanli, Jingfeng Zhou, Fang Xu, et al.. (2016). Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia. Journal of Clinical Investigation. 126(10). 3961–3980. 135 indexed citations
11.
Jin, Yanli, Danian Nie, Juan Li, et al.. (2016). Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin. Clinical Cancer Research. 23(11). 2842–2855. 37 indexed citations
12.
Jin, Yanli, Yiwu Yao, Li Chen, et al.. (2016). Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib. Theranostics. 6(11). 1947–1962. 28 indexed citations
13.
Jin, Yanli, Bingchen Han, Ruprecht Wiedemeyer, et al.. (2014). FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer. Annals of Surgical Oncology. 21(S4). 758–766. 35 indexed citations
15.
Jin, Yanli, Zhongzheng Lu, Ke Ding, et al.. (2010). Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species. Cancer Research. 70(6). 2516–2527. 261 indexed citations
16.
Jin, Yanli, Zhongzheng Lu, Qi Chen, et al.. (2010). The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation. Molecular Cancer Therapeutics. 9(1). 211–223. 25 indexed citations
17.
Shi, Xianping, Yanli Jin, Chao Cheng, et al.. (2009). Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation. Clinical Cancer Research. 15(5). 1686–1697. 98 indexed citations
18.
Jin, Yanli, Qi Chen, Zhongzheng Lu, Bo Chen, & Jingxuan Pan. (2009). Triptolide abrogates oncogene FIP1L1‐PDGFRα addiction and induces apoptosis in hypereosinophilic syndrome. Cancer Science. 100(11). 2210–2217. 15 indexed citations
19.
Jin, Yanli, Qi Chen, Xianping Shi, et al.. (2009). Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Science. 100(7). 1335–1343. 22 indexed citations
20.
Rigano, Maria Manuela, M. Lucrecia Alvarez, Julia Pinkhasov, et al.. (2004). Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Reports. 22(7). 502–508. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026